Extracellular proteolysis of reelin by tissue plasminogen activator following synaptic potentiation

Neuroscience

Volumn 274, Issue , 2014, Pages 299-307

  Trotter, J H ^a,b   Lussier, A L ^a,b   Psilos, K E ^a,b   Mahoney, H L ^a,b   Sponaugle, A E ^a,b   Hoe, H S ^c   Rebeck, G W ^c   Weeber, E J ^a,b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Hippocampus; Long term potentiation; Reelin; Tetraethylammonium chloride; Tissue plasminogen activator (tPA)

Indexed keywords

EPIDERMAL GROWTH FACTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; REELIN; TETRYLAMMONIUM CHLORIDE; TISSUE PLASMINOGEN ACTIVATOR; NERVE CELL ADHESION MOLECULE; NERVE PROTEIN; POTASSIUM CHANNEL BLOCKING AGENT; RECOMBINANT PROTEIN; REELIN PROTEIN; SCLEROPROTEIN; SERINE PROTEINASE; TETRYLAMMONIUM;

ANIMAL TISSUE; ARTICLE; BRAIN; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; KNOCKOUT MOUSE; LONG TERM POTENTIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROCESSING; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; UPREGULATION; WILD TYPE; ANIMAL; C57BL MOUSE; DRUG EFFECTS; EXTRACELLULAR SPACE; GENETICS; HEK293 CELL LINE; HIPPOCAMPUS; HUMAN; MALE; METABOLISM; PHYSIOLOGY; TISSUE CULTURE TECHNIQUE;

ANIMALS; CELL ADHESION MOLECULES, NEURONAL; EXTRACELLULAR MATRIX PROTEINS; EXTRACELLULAR SPACE; HEK293 CELLS; HIPPOCAMPUS; HUMANS; LONG-TERM POTENTIATION; MALE; MICE, INBRED C57BL; MICE, KNOCKOUT; NERVE TISSUE PROTEINS; POTASSIUM CHANNEL BLOCKERS; PROTEOLYSIS; RECOMBINANT PROTEINS; SERINE ENDOPEPTIDASES; TETRAETHYLAMMONIUM; TISSUE CULTURE TECHNIQUES; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84902668553     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2014.05.046     Document Type: Article

References (74)

1. Aniksztejn L., Ben-Ari Y. Novel form of long-term potentiation produced by a K+ channel blocker in the hippocampus. Nature 1991, 349:67-69.
2. Balmaceda V., Cuchillo-Ibanez I., Pujadas L., Garcia-Ayllon M.S., Saura C.A., Nimpf J., Soriano E., Saez-Valero J. ApoER2 processing by presenilin-1 modulates reelin expression. FASEB J: Off Pub Fed Am Soc Exp Biol 2014, 28:1543-1554.
3. Barnes P., Thomas K.L. Proteolysis of proBDNF is a key regulator in the formation of memory. PLoS One 2008, 3:e3248.
4. Botella-Lopez A., Burgaya F., Gavin R., Garcia-Ayllon M.S., Gomez-Tortosa E., Pena-Casanova J., Urena J.M., Del Rio J.A., Blesa R., Soriano E., Saez-Valero J. Reelin expression and glycosylation patterns are altered in Alzheimer's disease. Proc Natl Acad Sci USA 2006, 103:5573-5578.
5. Botella-Lopez A., Cuchillo-Ibanez I., Cotrufo T., Mok S.S., Li Q.X., Barquero M.S., Dierssen M., Soriano E., Saez-Valero J. Beta-amyloid controls altered reelin expression and processing in Alzheimer's disease. Neurobiol Dis 2010, 37:682-691.
6. Chen Y., Kundakovic M., Agis-Balboa R.C., Pinna G., Grayson D.R. Induction of the reelin promoter by retinoic acid is mediated by Sp1. J Neurochem 2007, 103:650-665.
7. Chen Z.L., Yu H., Yu W.M., Pawlak R., Strickland S. Proteolytic fragments of laminin promote excitotoxic neurodegeneration by up-regulation of the KA1 subunit of the kainate receptor. J Cell Biol 2008, 183:1299-1313.
8. Chin J., Massaro C.M., Palop J.J., Thwin M.T., Yu G.Q., Bien-Ly N., Bender A., Mucke L. Reelin depletion in the entorhinal cortex of human amyloid precursor protein transgenic mice and humans with Alzheimer's disease. J Neurosci 2007, 27:2727-2733.
9. Cubelos B., Sebastian-Serrano A., Kim S., Redondo J.M., Walsh C., Nieto M. Cux-1 and Cux-2 control the development of reelin expressing cortical interneurons. Dev Neurobiol 2008, 68:917-925.
10. D'Arcangelo G., Homayouni R., Keshvara L., Rice D.S., Sheldon M., Curran T. Reelin is a ligand for lipoprotein receptors. Neuron 1999, 24:471-479.
11. D'Arcangelo G., Miao G.G., Chen S.C., Soares H.D., Morgan J.I., Curran T. A protein related to extracellular matrix proteins deleted in the mouse mutant reeler. Nature 1995, 374:719-723.
12. D'Arcangelo G., Nakajima K., Miyata T., Ogawa M., Mikoshiba K., Curran T. Reelin is a secreted glycoprotein recognized by the CR-50 monoclonal antibody. J Neurosci 1997, 17:23-31.
13. de Bergeyck V., Nakajima K., Lambert de Rouvroit C., Naerhuyzen B., Goffinet A.M., Miyata T., Ogawa M., Mikoshiba K. A truncated Reelin protein is produced but not secreted in the 'Orleans' reeler mutation (Reln[rl-Orl]). Brain Res Mol Brain Res 1997, 50:85-90.
14. Duit S., Mayer H., Blake S.M., Schneider W.J., Nimpf J. Differential functions of ApoER2 and very low density lipoprotein receptor in Reelin signaling depend on differential sorting of the receptors. J Biol Chem 2010, 285:4896-4908.
15. Dulabon L., Olson E.C., Taglienti M.G., Eisenhuth S., McGrath B., Walsh C.A., Kreidberg J.A., Anton E.S. Reelin binds alpha3beta1 integrin and inhibits neuronal migration. Neuron 2000, 27:33-44.
16. Duveau V., Madhusudan A., Caleo M., Knuesel I., Fritschy J.M. Impaired reelin processing and secretion by Cajal-Retzius cells contributes to granule cell dispersion in a mouse model of temporal lobe epilepsy. Hippocampus 2011, 21:935-944.
17. Echeverry R., Wu J., Haile W.B., Guzman J., Yepes M. Tissue-type plasminogen activator is a neuroprotectant in the mouse hippocampus. J Clin Invest 2010, 120:2194-2205.
18. Erbel-Sieler C., Dudley C., Zhou Y., Wu X., Estill S.J., Han T., Diaz-Arrastia R., Brunskill E.W., Potter S.S., McKnight S.L. Behavioral and regulatory abnormalities in mice deficient in the NPAS1 and NPAS3 transcription factors. Proc Natl Acad Sci U S A 2004, 101:13648-13653.
19. Fatemi S.H., Earle J.A., McMenomy T. Reduction in Reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression. Mol Psychiatry 2000, 5(654-663):571.
20. Groc L., Choquet D., Stephenson F.A., Verrier D., Manzoni O.J., Chavis P. NMDA receptor surface trafficking and synaptic subunit composition are developmentally regulated by the extracellular matrix protein Reelin. J Neurosci 2007, 27:10165-10175.
21. Herring A., Donath A., Steiner K.M., Widera M.P., Hamzehian S., Kanakis D., Kolble K., ElAli A., Hermann D.M., Paulus W., Keyvani K. Reelin depletion is an early phenomenon of Alzheimer's pathology. J Alzheimers Dis 2012, 30:963-979.
22. Hiesberger T., Trommsdorff M., Howell B.W., Goffinet A., Mumby M.C., Cooper J.A., Herz J. Direct binding of Reelin to VLDL receptor and ApoE receptor 2 induces tyrosine phosphorylation of disabled-1 and modulates tau phosphorylation. Neuron 1999, 24:481-489.
23. Hirotsune S., Takahara T., Sasaki N., Hirose K., Yoshiki A., Ohashi T., Kusakabe M., Murakami Y., Muramatsu M., Watanabe S., et al. The reeler gene encodes a protein with an EGF-like motif expressed by pioneer neurons. Nat Genet 1995, 10:77-83.
24. Hisanaga A., Morishita S., Suzuki K., Sasaki K., Koie M., Kohno T., Hattori M. A disintegrin and metalloproteinase with thrombospondin motifs 4 (ADAMTS-4) cleaves Reelin in an isoform-dependent manner. FEBS Lett 2012, 586:3349-3353.
25. Hoe H.S., Lee K.J., Carney R.S., Lee J., Markova A., Lee J.Y., Howell B.W., Hyman B.T., Pak D.T., Bu G., Rebeck G.W. Interaction of reelin with amyloid precursor protein promotes neurite outgrowth. J Neurosci 2009, 29:7459-7473.
26. Hong C., Duit S., Jalonen P., Out R., Scheer L., Sorrentino V., Boyadjian R., Rodenburg K.W., Foley E., Korhonen L., Lindholm D., Nimpf J., van Berkel T.J., Tontonoz P., Zelcer N. The E3 ubiquitin ligase IDOL induces the degradation of the low density lipoprotein receptor family members VLDLR and ApoER2. The Journal of biological chemistry 2010, 285:19720-19726.
27. Impagnatiello F., Guidotti A.R., Pesold C., Dwivedi Y., Caruncho H., Pisu M.G., Uzunov D.P., Smalheiser N.R., Davis J.M., Pandey G.N., Pappas G.D., Tueting P., Sharma R.P., Costa E. A decrease of reelin expression as a putative vulnerability factor in schizophrenia. Proc Natl Acad Sci U S A 1998, 95:15718-15723.
28. Jossin Y., Gui L., Goffinet A.M. Processing of reelin by embryonic neurons is important for function in tissue but not in dissociated cultured neurons. J Neurosci 2007, 27:4243-4252.
29. Jossin Y., Ignatova N., Hiesberger T., Herz J., Lambert de Rouvroit C., Goffinet A.M. The central fragment of reelin, generated by proteolytic processing in vivo, is critical to its function during cortical plate development. J Neurosci 2004, 24:514-521.
30. Kang H.M., Kalnoski M.H., Frederick M., Chandler W.L. The kinetics of plasmin inhibition by aprotinin in vivo. Thromb Res 2005, 115:327-340.
31. Kanterewicz B.I., Urban N.N., McMahon D.B., Norman E.D., Giffen L.J., Favata M.F., Scherle P.A., Trzskos J.M., Barrionuevo G., Klann E. The extracellular signal-regulated kinase cascade is required for NMDA receptor-independent LTP in area CA1 but not area CA3 of the hippocampus. J Neurosci 2000, 20:3057-3066.
32. Koie M., Okumura K., Hisanaga A., Kamei T., Sasaki K., Deng M., Baba A., Kohno T., Hattori M. Cleavage within reelin repeat 3 regulates the duration and range of signaling activity of reelin. J Biol Chem 2014, 289:12922-12930.
33. Krstic D., Rodriguez M., Knuesel I. Regulated proteolytic processing of reelin through interplay of tissue plasminogen activator (tPA), ADAMTS-4, ADAMTS-5, and their modulators. PLoS One 2012, 7:e47793.
34. Kubo K., Mikoshiba K., Nakajima K. Secreted reelin molecules form homodimers. Neurosci Res 2002, 43:381-388.
35. Lacor P.N., Grayson D.R., Auta J., Sugaya I., Costa E., Guidotti A. Reelin secretion from glutamatergic neurons in culture is independent from neurotransmitter regulation. Proc Natl Acad Sci USA 2000, 97:3556-3561.
36. Lambert de Rouvroit C., de Bergeyck V., Cortvrindt C., Bar I., Eeckhout Y., Goffinet A.M. Reelin, the extracellular matrix protein deficient in reeler mutant mice, is processed by a metalloproteinase. Exp Neurol 1999, 156:214-217.
37. Liu J.N., Gurewich V. A comparative study of the promotion of tissue plasminogen activator and pro-urokinase-induced plasminogen activation by fragments D and E-2 of fibrin. J Clin Invest 1991, 88:2012-2017.
38. Liu R.M., van Groen T., Katre A., Cao D., Kadisha I., Ballinger C., Wang L., Carroll S.L., Li L. Knockout of plasminogen activator inhibitor 1 gene reduces amyloid beta peptide burden in a mouse model of Alzheimer's disease. Neurobiol Aging 2011, 32:1079-1089.
39. Lochner J.E., Honigman L.S., Grant W.F., Gessford S.K., Hansen A.B., Silverman M.A., Scalettar B.A. Activity-dependent release of tissue plasminogen activator from the dendritic spines of hippocampal neurons revealed by live-cell imaging. J Neurobiol 2006, 66:564-577.
40. Lochner J.E., Spangler E., Chavarha M., Jacobs C., McAllister K., Schuttner L.C., Scalettar B.A. Efficient copackaging and cotransport yields postsynaptic colocalization of neuromodulators associated with synaptic plasticity. Dev Neurobiol 2008, 68:1243-1256.
41. Lottenberg R., Sjak-Shie N., Fazleabas A.T., Roberts R.M. Aprotinin inhibits urokinase but not tissue-type plasminogen activator. Thromb Res 1988, 49:549-556.
42. Lussier A.L., Caruncho H.J., Kalynchuk L.E. Repeated exposure to corticosterone, but not restraint, decreases the number of reelin-positive cells in the adult rat hippocampus. Neurosci Lett 2009, 460:170-174.
43. Lussier A.L., Lebedeva K., Fenton E.Y., Guskjolen A., Caruncho H.J., Kalynchuk L.E. The progressive development of depression-like behavior in corticosterone-treated rats is paralleled by slowed granule cell maturation and decreased reelin expression in the adult dentate gyrus. Neuropharmacology 2013, 71C:174-183.
44. Lussier A.L., Romay-Tallon R., Kalynchuk L.E., Caruncho H.J. Reelin as a putative vulnerability factor for depression: examining the depressogenic effects of repeated corticosterone in heterozygous reeler mice. Neuropharmacology 2011, 60:1064-1074.
45. Miller C.A., Sweatt J.D. Covalent modification of DNA regulates memory formation. Neuron 2007, 53:857-869.
46. Nagappan G., Zaitsev E., Senatorov V.V., Yang J., Hempstead B.L., Lu B. Control of extracellular cleavage of ProBDNF by high frequency neuronal activity. Proc Natl Acad Sci USA 2009, 106:1267-1272.
47. Nakajima K., Mikoshiba K., Miyata T., Kudo C., Ogawa M. Disruption of hippocampal development in vivo by CR-50 mAb against reelin. Proc Natl Acad Sci USA 1997, 94:8196-8201.
48. Nakano Y., Kohno T., Hibi T., Kohno S., Baba A., Mikoshiba K., Nakajima K., Hattori M. The extremely conserved C-terminal region of reelin is not necessary for secretion but is required for efficient activation of downstream signaling. J Biol Chem 2007, 282:20544-20552.
49. Niu S., Renfro A., Quattrocchi C.C., Sheldon M., D'Arcangelo G. Reelin promotes hippocampal dendrite development through the VLDLR/ApoER2-Dab1 pathway. Neuron 2004, 41:71-84.
50. Niu S., Yabut O., D'Arcangelo G. The reelin signaling pathway promotes dendritic spine development in hippocampal neurons. J Neurosci 2008, 28:10339-10348.
51. Novak J.F., Hayes J.D., Nishimoto S.K. Plasmin-mediated proteolysis of osteocalcin. J Bone Miner Res 1997, 12:1035-1042.
52. Pang P.T., Teng H.K., Zaitsev E., Woo N.T., Sakata K., Zhen S., Teng K.K., Yung W.H., Hempstead B.L., Lu B. Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal plasticity. Science 2004, 306:487-491.
53. Pujadas L., Gruart A., Bosch C., Delgado L., Teixeira C.M., Rossi D., de Lecea L., Martinez A., Delgado-Garcia J.M., Soriano E. Reelin regulates postnatal neurogenesis and enhances spine hypertrophy and long-term potentiation. J Neurosci 2010, 30:4636-4649.
54. Qian Z., Gilbert M.E., Colicos M.A., Kandel E.R., Kuhl D. Tissue-plasminogen activator is induced as an immediate-early gene during seizure, kindling and long-term potentiation. Nature 1993, 361:453-457.
55. Qiu S., Korwek K.M., Pratt-Davis A.R., Peters M., Bergman M.Y., Weeber E.J. Cognitive disruption and altered hippocampus synaptic function in reelin haploinsufficient mice. Neurobiol Learn Mem 2006, 85:228-242.
56. Qiu S., Weeber E.J. Reelin signaling facilitates maturation of CA1 glutamatergic synapses. J Neurophysiol 2007, 97:2312-2321.
57. Ramos-Moreno T., Galazo M.J., Porrero C., Martinez-Cerdeno V., Clasca F. Extracellular matrix molecules and synaptic plasticity: immunomapping of intracellular and secreted reelin in the adult rat brain. Eur J Neurosci 2006, 23:401-422.
58. Ranby M., Brandstrom A. Biological control of tissue plasminogen activator-mediated fibrinolysis. Enzyme 1988, 40:130-143.
59. Rodriguez M.A., Pesold C., Liu W.S., Kriho V., Guidotti A., Pappas G.D., Costa E. Colocalization of integrin receptors and reelin in dendritic spine postsynaptic densities of adult nonhuman primate cortex. Proc Natl Acad Sci USA 2000, 97:3550-3555.
60. Rogers J.T., Rusiana I., Trotter J., Zhao L., Donaldson E., Pak D.T., Babus L.W., Peters M., Banko J.L., Chavis P., Rebeck G.W., Hoe H.S., Weeber E.J. Reelin supplementation enhances cognitive ability, synaptic plasticity, and dendritic spine density. Learn Mem 2011, 18:558-564.
61. Silverstein R.L., Leung L.L., Harpel P.C., Nachman R.L. Complex formation of platelet thrombospondin with plasminogen. Modulation of activation by tissue activator. J Clin Invest 1984, 74:1625-1633.
62. Teesalu T., Kulla A., Simisker A., Siren V., Lawrence D.A., Asser T., Vaheri A. Tissue plasminogen activator and neuroserpin are widely expressed in the human central nervous system. Thromb Haemost 2004, 92:358-368.
63. Thewke D.P., Seeds N.W. The expression of mRNAs for hepatocyte growth factor/scatter factor, its receptor c-met, and one of its activators tissue-type plasminogen activator show a systematic relationship in the developing and adult cerebral cortex and hippocampus. Brain Res 1999, 821:356-367.
64. Tinnes S., Ringwald J., Haas C.A. TIMP-1 inhibits the proteolytic processing of reelin in experimental epilepsy. FASEB J: Off Pub Fed Am Soc Exp Biol 2013, 27:2542-2552.
65. Tinnes S., Schafer M.K., Flubacher A., Munzner G., Frotscher M., Haas C.A. Epileptiform activity interferes with proteolytic processing of Reelin required for dentate granule cell positioning. FASEB J 2011, 25:1002-1013.
66. Trommsdorff M., Gotthardt M., Hiesberger T., Shelton J., Stockinger W., Nimpf J., Hammer R.E., Richardson J.A., Herz J. Reeler/disabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and ApoE receptor 2. Cell 1999, 97:689-701.
67. Trotter J.H., Klein M., Jinwal U.K., Abisambra J.F., Dickey C.A., Tharkur J., Masiulis I., Ding J., Locke K.G., Rickman C.B., Birch D.G., Weeber E.J., Herz J. ApoER2 function in the establishment and maintenance of retinal synaptic connectivity. J Neurosci 2011, 31:14413-14423.
68. Trotter J.H., Lee G.H., Kazdoba T.M., Crowell B., Domogauer J., Mahoney H.M., Franco S.J., Müller U., Weeber E.J., D'Arcangelo G. Dab1 is required for synaptic plasticity and associative learning. J Neurosci 2013, 33:15652-15668.
69. Utsunomiya-Tate N., Kubo K., Tate S., Kainosho M., Katayama E., Nakajima K., Mikoshiba K. Reelin molecules assemble together to form a large protein complex, which is inhibited by the function-blocking CR-50 antibody. Proc Natl Acad Sci USA 2000, 97:9729-9734.
70. Ventruti A., Kazdoba T.M., Niu S., D'Arcangelo G. Reelin deficiency causes specific defects in the molecular composition of the synapses in the adult brain. Neuroscience 2011, 189:32-42.
71. Wang G.S., Hong C.J., Yen T.Y., Huang H.Y., Ou Y., Huang T.N., Jung W.G., Kuo T.Y., Sheng M., Wang T.F., Hsueh Y.P. Transcriptional modification by a CASK-interacting nucleosome assembly protein. Neuron 2004, 42:113-128.
72. Weeber E.J., Beffert U., Jones C., Christian J.M., Forster E., Sweatt J.D., Herz J. Reelin and ApoE receptors cooperate to enhance hippocampal synaptic plasticity and learning. J Biol Chem 2002, 277:39944-39952.
73. Yasui N., Nogi T., Takagi J. Structural basis for specific recognition of reelin by its receptors. Structure 2010, 18:320-331.
74. Zhuo M., Holtzman D.M., Li Y., Osaka H., DeMaro J., Jacquin M., Bu G. Role of tissue plasminogen activator receptor LRP in hippocampal long-term potentiation. J Neurosci 2000, 20:542-549.